Lilly to Participate in SVB Securities Global Biopharma Conference
Eli Lilly and Company (NYSE: LLY) will participate in the SVB Securities Global Biopharma Conference on February 16, 2023. Ilya Yuffa, Executive Vice President and President of Lilly International, will take part in a virtual fireside chat at 12 p.m. Eastern time. A live audio webcast will be available on Lilly's Investor website, with a replay accessible for approximately 90 days thereafter. Lilly has been a leader in creating innovative treatments, helping over 47 million people globally. Their research focuses on serious health challenges, including diabetes, obesity, Alzheimer's, and certain cancers.
- None.
- None.
A live audio webcast will be available on the "Webcasts & Presentations" section of
About
Refer to: | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-svb-securities-global-biopharma-conference-301739752.html
SOURCE